Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 ...

For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased risk for psychiatric adverse events or worsening ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

To fully understand the role of GLP-1RAs in managing diabetes and depression, further randomized controlled trials and long-term studies are needed, Guo added. Reference: Tang H, Lu Y, Donahoo WT, et ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

GLP-1s are gaining interest for their impact on weight, blood sugar, and possibly mood in bipolar disorder. Here’s what ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

There were associations for GLP-1 RA treatment vs placebo with improvements in restrained eating and emotional eating behavior and in mental health-related QOL. HealthDay News — For patients ...

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL. (HealthDay News) — For patients with overweight/obesity and/or diabetes ...